Viatris Archives - Catalyst Daily

Viatris Inc. ($VTRS) Announces Phase 3 Blepharitis Study Misses Key Goal

NewsDesk CD - July 18, 2025 7:20 am

Viatris Inc. (VTRS) reported that its Phase 3 study evaluating pimecrolimus 0.3% ophthalmic ointment for blepharitis did not achieve the primary endpoint of complete...

Brookfield Renewable ($BEP) Commits $1 Billion to Raise Equity in Isagen...

July 18, 2025 4:45 pm

FONAR ($FONR) Jumps 3% After-Hours to $16.40 on Acquisition Buzz

July 18, 2025 4:33 pm

FONAR Corporation ($FONR) Confirms Receipt of Supplemental Offer from Timothy Damadian...

July 18, 2025 4:29 pm

Tag: Viatris

Viatris Inc. ($VTRS) Announces Phase 3 Blepharitis Study Misses Key Goal

Brookfield Renewable ($BEP) Commits $1 Billion to Raise Equity in Isagen...

FONAR ($FONR) Jumps 3% After-Hours to $16.40 on Acquisition Buzz

FONAR Corporation ($FONR) Confirms Receipt of Supplemental Offer from Timothy Damadian...